Beurs gesloten -
Swiss Exchange
17:31:30 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
71,6
CHF
|
-0,69%
|
|
+0,28%
|
+40,67%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Marktkapitalisatie
1 |
1.169
|
1.033
|
1.133
|
1.067
|
1.013
|
1.177
|
1.177
|
-
|
Bedrijfswaarde
1 |
978,1
|
929,6
|
1.088
|
1.014
|
945,3
|
831,9
|
1.067
|
982,5
|
K/w-verhouding
|
-65
x
|
-42,3
x
|
-143
x
|
49,2
x
|
58,9
x
|
771
x
|
10,6
x
|
10,2
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
1,7%
|
3,65%
|
2,86%
|
1,24%
|
Marktkapitalisatie/omzet
|
17,8
x
|
16,5
x
|
18,6
x
|
16,4
x
|
9,92
x
|
9,1
x
|
4,49
x
|
4,86
x
|
Bedrijfswaarde/omzet
|
14,9
x
|
14,9
x
|
17,9
x
|
15,6
x
|
9,26
x
|
8,6
x
|
4,07
x
|
4,06
x
|
Bedrijfswaarde/EBITDA
|
-80,6
x
|
-142
x
|
84,1
x
|
54,8
x
|
22,6
x
|
31,4
x
|
6,11
x
|
6,72
x
|
Bedrijfswaarde/FCF
|
-81,1
x
|
-44,1
x
|
123
x
|
142
x
|
32,9
x
|
25
x
|
11,4
x
|
7,66
x
|
FCF Yield
|
-1,23%
|
-2,27%
|
0,81%
|
0,7%
|
3,04%
|
4%
|
8,78%
|
13,1%
|
Price to Book
|
2,61
x
|
2,6
x
|
2,83
x
|
2,09
x
|
2,2
x
|
2,06
x
|
2,29
x
|
1,95
x
|
Aantal aandelen (in duizenden)
|
15.002
|
14.623
|
14.463
|
16.838
|
16.384
|
16.053
|
16.053
|
-
|
Referentieprijs
2 |
77,95
|
70,64
|
78,34
|
63,36
|
61,81
|
73,32
|
73,32
|
73,32
|
Datum van publicatie
|
29/03/19
|
3/04/20
|
26/03/21
|
23/03/22
|
23/03/23
|
20/03/24
|
-
|
-
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Omzet
1 |
65,62
|
62,5
|
60,95
|
65,07
|
102,1
|
96,72
|
261,9
|
241,9
|
EBITDA
1 |
-12,14
|
-6,552
|
12,94
|
18,5
|
41,91
|
26,49
|
174,6
|
146,3
|
Bedrijfsresultaat (EBIT)
1 |
-16,62
|
-12,31
|
6,905
|
11,1
|
28,06
|
12,23
|
158,1
|
128,1
|
Operationele Marge
|
-25,33%
|
-19,69%
|
11,33%
|
17,06%
|
27,48%
|
12,64%
|
60,38%
|
52,94%
|
Resultaat voor belastingen (EBT)
1 |
-17,46
|
-21,3
|
-6,931
|
24
|
24,47
|
7,611
|
162,5
|
149,9
|
Nettowinst (verlies)
1 |
-18,06
|
-24,49
|
-7,901
|
21,67
|
17,22
|
1,147
|
111
|
102,1
|
Nettomarge
|
-27,52%
|
-39,19%
|
-12,96%
|
33,31%
|
16,87%
|
1,19%
|
42,38%
|
42,19%
|
WPA
2 |
-1,200
|
-1,669
|
-0,5460
|
1,287
|
1,049
|
0,0710
|
6,895
|
7,153
|
Free Cash Flow
1 |
-12,06
|
-21,09
|
8,865
|
7,124
|
28,71
|
33,31
|
93,7
|
128,3
|
FCF-marge
|
-18,38%
|
-33,75%
|
14,54%
|
10,95%
|
28,12%
|
34,44%
|
35,78%
|
53,01%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
68,51%
|
38,51%
|
68,5%
|
125,76%
|
53,65%
|
87,66%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
32,87%
|
166,68%
|
2.904,1%
|
84,41%
|
125,66%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
1,050
|
2,000
|
2,100
|
0,9128
|
Datum van publicatie
|
29/03/19
|
3/04/20
|
26/03/21
|
23/03/22
|
23/03/23
|
20/03/24
|
-
|
-
|
Fiscaal tijdperk: december |
2019 S1
|
2019 S2
|
2020 S1
|
2021 S1
|
2022 S1
|
2022 S2
|
2023 S1
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 S2
|
---|
Omzet
1 |
21,51
|
40,99
|
25,88
|
28,42
|
41,51
|
60,58
|
43,66
|
131,3
|
35,8
|
142,5
|
42,8
|
113,9
|
EBITDA
|
-
|
8,041
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-17,2
|
4,894
|
2,662
|
0,008
|
8,108
|
19,95
|
7,123
|
108,3
|
11,1
|
94,6
|
15,44
|
66,9
|
Operationele Marge
|
-79,98%
|
11,94%
|
10,28%
|
0,03%
|
19,53%
|
32,93%
|
16,31%
|
82,49%
|
30,99%
|
66,39%
|
36,07%
|
58,74%
|
Resultaat voor belastingen (EBT)
|
-22,62
|
1,315
|
-5,331
|
-4,667
|
9,089
|
15,38
|
3,673
|
-
|
-
|
95
|
-
|
67,5
|
Nettowinst (verlies)
|
-20,78
|
-3,712
|
-3,015
|
-5,741
|
7,896
|
9,329
|
1,486
|
-
|
-
|
68,4
|
-
|
48,6
|
Nettomarge
|
-96,63%
|
-9,06%
|
-11,65%
|
-20,2%
|
19,02%
|
15,4%
|
3,4%
|
-
|
-
|
48%
|
-
|
42,67%
|
WPA
|
-1,407
|
-0,2620
|
-0,2080
|
-0,3990
|
0,4760
|
0,5730
|
0,0920
|
-
|
-
|
4,260
|
-
|
3,020
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
30/07/19
|
3/04/20
|
30/07/20
|
30/07/21
|
28/07/22
|
23/03/23
|
26/07/23
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
191
|
103
|
44,7
|
52,3
|
67,4
|
48,4
|
110
|
195
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-12,1
|
-21,1
|
8,87
|
7,12
|
28,7
|
33,3
|
93,7
|
128
|
ROE (netto-inkomsten/eigen vermogen)
|
-3,95%
|
-5,83%
|
-
|
-
|
3,58%
|
0,26%
|
22,1%
|
18,8%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
2 |
29,90
|
27,10
|
27,70
|
30,20
|
28,10
|
26,60
|
32,00
|
37,50
|
Cashflow per aandeel
2 |
-0,6800
|
-
|
0,9000
|
0,7500
|
2,020
|
2,090
|
5,780
|
2,920
|
Capex
1 |
1,9
|
2,25
|
4,12
|
-
|
4,52
|
3,35
|
9,9
|
6,89
|
Capex/omzet
|
2,89%
|
3,59%
|
6,76%
|
-
|
4,42%
|
3,46%
|
3,78%
|
2,85%
|
Datum van publicatie
|
29/03/19
|
3/04/20
|
26/03/21
|
23/03/22
|
23/03/23
|
20/03/24
|
-
|
-
|
Laatste slotkoers
73,32
EUR Gemiddelde koersdoel
95,38
EUR Spread / Gemiddelde doel +30,08% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +40,67% | 1,26 mld. | | +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|